Ypsomed Holding AG 2025 AR2

The report highlights Ypsomed's transition to a pure-play injection specialist following the sale of its pen needle, blood-glucose monitoring, and diabetes care businesses. In the 2024/25 financial year, the company achieved strong operating sales growth of 38% and increased its operating profit to CHF 140.5 million. On the sustainability front, Ypsomed's short-term climate targets until 2030 and long-term net-zero targets for 2040 were approved by the Science Based Targets initiative (SBTi). Additionally, the company improved its Carbon Disclosure Project (CDP) rating to a 'B' and successfully obtained ISCC+ certification at its Burgdorf, Solothurn, and Schwerin sites.

Company: Ypsomed Holding AG

Sector: Health Care

Country: Switzerland

Year: 2025

Type: AR2

Pages: 148

Back to company

Ypsomed Holding AG

Ypsomed Holding AG 2025 Annual Report

Annual Report

The report highlights Ypsomed's transition to a pure-play injection specialist following the sale of its pen needle, blood-glucose monitoring, and diabetes care businesses. In the 2024/25 financial year, the company achieved strong operating sales growth of 38% and increased its operating profit to CHF 140.5 million. On the sustainability front, Ypsomed's short-term climate targets until 2030 and long-term net-zero targets for 2040 were approved by the Science Based Targets initiative (SBTi). Additionally, the company improved its Carbon Disclosure Project (CDP) rating to a 'B' and successfully obtained ISCC+ certification at its Burgdorf, Solothurn, and Schwerin sites.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2025

Reporting Period

Apr 1, 2024 - Mar 31, 2025

Fiscal Year

2025

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Scope 3:

Energy Consumption

Renewable Energy

Total Waste

Women on Board

Women in Management

Net Zero Target

Employees